Home > Healthcare > Ultrasonic Tissue Ablation System Market
Ultrasonic Tissue Ablation System Market Size
Ultrasonic Tissue Ablation System Market Size is poised to grow considerably over 2024-2032, driven by the adoption of advanced medical instruments. The growing awareness among people about the early disease diagnosis and treatment procedures for various chronic diseases is contributing to the industry expansion.
The increasing prevalence of neurological disease, cardiac disorders, gynecological disease, and others escalates the product demand. As per Global Heart & Circulatory Diseases Factsheet published in January 2024, around 200 million individuals are currently living with coronary heart disease, accounting for 110 million being men and 80 million being women globally. The increasing initiatives to enhance healthcare infrastructure is anticipated to create opportunities for the ultrasonic tissue ablation system manufacturers in the upcoming years.
Ultrasonic Tissue Ablation System Market Trends
There is a focus on enhancing precision and efficiency in tissue ablation procedures. Innovations such as real-time imaging guidance systems and the integration of AI contribute to more accurate treatment planning and execution. Additionally, there is a growing emphasis on developing minimally invasive ultrasonic ablation techniques, reducing patient recovery times, and improving overall procedural outcomes. The focus on innovations and their integration will shape the industry outlook.
Ultrasonic Tissue Ablation System Market Analysis
Based on product type, high-intensity focused ultrasound (HIFU) segment is projected to grow notably over the forecast period, attributed to its increasing application in the treatment of both primary as well as metastatic tumors. The rising prevalence of liver cancer is expected to further drive the segmental growth in the coming years. As per American Cancer Society, each year, over 800,000 individuals are diagnosed with liver cancer globally.
In terms of application, cancer segment is expected to record substantial expansion through 2032, backed by the increasing awareness among people about cancer diagnosis and treatment across developed & developing nations. As per PAHO, there were approximately 20 million new cases of cancer and 10 million deaths from cancer across the globe in 2020. Rising R&D investments in cancer treatment by the key business players is stimulating the industry gains.
North America is expected to hold a substantial share in ultrasonic tissue ablation system market by 2032, attributed to the increasing investments in the healthcare infrastructure. As per the data by AHA.org, around 133 million Americans – around half the population – suffer from at least one chronic illness, such as hypertension, cardiac disease, and arthritis. The rising cases of chronic disorders, requiring advanced treatment is further contributing to the regional market progression.
Ultrasonic Tissue Ablation System Market Share
Some of the major ultrasonic tissue ablation system industry players include:
- Chongqing Haifu Medical Technology
- Integra LifeSciences
- Shanghai A&S Science Technology Development
- Mianyang Sonic Electronic
- Misonix
- Insightec
- Ethicon (Johnson & Johnson)
- Alpinion Medical Systems (ILJIN Holdings Co. Ltd)
- Theraclion
These market players are inclined towards finding innovative solutions to effectively cater to consumer demand and gain a competitiveness edge.
Ultrasonic Tissue Ablation System Industry News
In November 2022, CMR Surgical (CMR), a global surgical robotics company, announced a collaborative agreement with Ethicon, a Johnson & Johnson MedTech company, to expand the range of options in surgical robotics and advanced laparoscopic instruments.